NO KNOWN PRODUCTS - UNVERIFIABLE ANNOUNCEMENTS - HEAVY DEBT - OTC SHELL RISK FLAG
Eco-Growth Strategies is an Oregon Corporation f/k/a Falcon Technologies
ECO-GROWTH STRATEGIES WYOMING REGISTRATION
Falcon Technologies was an Inactive Oregon Corporation between April 15, 2011 and May 9, 2019
Delgado let Falcon go dormant to allow the California Statute of Limitations on his business debt to run
Delgado filed an Attorney Letter dated March 3, 2019 which claimed FLCN redomiciled to Wyoming in January 2019. This was a false statement.
CORPORATE ADDRESS IS A VIRTUAL OFFICE IN NEW YORK AS WELL AS DELGADO'S SECURITY LAWYERS OFFICE
90 Broad Street, 2nd FL
New York, NY 10004
FALCON HAS NO FOREIGN REGISTRATION ON FILE WITH CALIFORNIA'S SECRETARY OF STATE
Falcon Technology Holdings, Inc. - FTB Suspended as of 02/03/2020
Eco-Growth Strategies, Inc. - No Record Found as of 02/03/2020
Falcon Technologies, Inc., which will do business in California as Falcon Technologies Engineering and Construction - FTB Suspended
ACCORDING TO THE 2018 ANNUAL REPORT, WILLIAM J. DELGADO IS THE SOLE BENEFICIAL SHAREHOLDER. THE ANNUAL REPORT HAS NO REFERENCE TO FUTURE PLANS EVEN THOUGH IT WAS UPLOADED 02/27/19, WELL AFTER THE COMPANY ATTEMPTED TO REDOMICILE
TO WYOMING ON FEBRUARY 11, 2019 UNDER THE NAME ECO-GROWTH STRATEGIES. THE WYOMING ARTICLES OF INCORPORATION DO NOT NAME DELGADO.
THE WYOMING ARTICLES CONTAIN AN AUTHORIZED SHARE COUNT OF 500,000,000 AND PREFERRED SHARE COUNT OF 10,000,000.
OTC MARKETS SECURITY DETAILS
A/S 100,000,000 as of 06/30/2019
O/S 19,531,847 as of 06/30/2019
FLOAT 5,086,101 as of 06/30/2019
WYOMING SECRETARY OF STATE SECURITY DETAILS
A/S 500,000,000 as of 02/11/2019
STOCK TRADES BEGAN THE DAY OF THE WYOMING FILING, FEBRUARY 11, 2019,
AND CONTINUED UNTIL THE DAY BEFORE THE DELINQUENT FLCN FILINGS WERE UPLOADED TO OTC MARKETS.
THAT'S 11 DAYS OF TRADING WITHOUT PUBLIC DISCLOSURE OR NEWS FROM WILLIAM J. DELGADO.
THE SHIFT TO ECO-GROWTH STRATEGIES WAS NOT PUBLIC KNOWLEDGE. THE WYOMING FILING DIDN'T NAME FLCN OR DELGADO.
HOW DID THE EARLY TRADERS LEARN ABOUT THE PENDING TRANSITION?
2018 ANNUAL REPORT SHOWS
NOTES FROM THE 2018 ANNUAL REPORT
(1) All income related assets (receivables, notes, costs in excess of billings) have been zeroed out. There
has been no activity in the last several years in these accounts or the attempts to collect said assets.
(2) All liability accounts have been adjusted accordingly. All of the liabilities, except for notes due to related party,
have exceeded the statute of limitations for the State of California, where such liabilities were incurred.
(3) William J. Delgado, CEO and sole director, on behalf of the shareholders of Falcon Technologies, Inc.,
initiated legal action against three of the former officers and directors of FLCN in 2009. Although legal
counsel was working on a contingency fee arrangement and the probability of success was positive, it was
determined by the company and legal counsel that collectability would be difficult, if not impossible.
The decision not to continue was made mutually by the company and the company’s legal counsel.
- Financial Update from Q3 2019 -
At September 30, 2019, we had cash and cash equivalents on hand of $2,004 and have very limited working capital.
We plan to increase our expense levels over 2019 levels to fund the company and its operations along with our direct sales efforts accordingly.
We expect to support these planned expense increases by raising additional capital.
FLUFF NEWS ANALYSIS
|DATE NEWS ISSUED ||ANNOUNCED ACTIONS ||COMPLETED (Y/N) |
|3/18/19 || Entrance into CBD Market ||N |
|3/21/19 || Filing of Provisional Patent for CBD Formulation to Treat Acne ||Unable to Verify |
|3/25/19 || LOI with Neutrisci to Manufacture Sublingual CBD Tablets |
Signing of Definitive Agreement Q2 2019
First Orders Expected early Q3 2019
|Unable to Verify |
|4/10/19 || Signing of Two-Year Exclusive Agreement with Stevia Corp to Sell/Market/Distribute Hemp |
using RealHempTM Brand with Option to Purchase
|Unable to Verify |
|4/25/19 || Filing of Provisional Patent using CBD to Treat Ulcers ||Unable to Verify |
|4/26/19 || Added Eczema, Psoriasis, Rosacea to Skincare Product Line ||N |
|5/9/19 || Added CBD Transdermal Sports Patch to Product Line ||N |
|5/15/19 || Sending Rep (Ken Maciora) to the FDA CBD Public Hearing - Maciora was a No Show ||N |
|5/29/19 || Formed Scientific Advisory Panel ||Unable to Verify |
|6/11/19 || Added Dr. Tin-Chuen Yeung to Advisory Panel ||Unable to Verify |
|6/26/19 || Ken Shamrock signs Licensing Deal ||Unable to Verify |
|7/24/19 || Filed Trademark Application for Dietary Supplement for Pets ||Unable to Verify |
|12/3/19 || Announced Opening of Extraction Facility ||Unable to Verify |
The above section will be managed by Moderator PhenixBleu.
Please review the reasons why posts get deleted. It's all about the terms each member agrees to upon registering their accounts.
Deletion of Posts